SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  RESOURCE CENTER  
  JOBS  
  SUBSCRIBE  
 RSS
  Thursday, March 11, 2010 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

Japanese medical technology
PRIME NEWS
Astellas launches $3.5 bn hostile bid for OSI Pharmaceuticals
Japan's Astellas Pharma has launched a hostile bid to acquire OSI Pharmaceuticals, a Nasdaq listed developer of molecular targeted therapies for oncology, diabetes and obesity
Japan pharma sales to decline to $84.6bn in 2018
A new report released recently said medicine sales in Japan will decline from $85.8bn in 2008 to $84.6bn in 2018. However, in local currency terms, the market will actually expand by a compound annual growth rate (CAGR) of 1.11%
TODAY'S NEWS
  Dr Anji Reddy: People's Doctor
  Obesity drug market to reach $600 mn by 2018
  GSK looks for acquisitions in India, says Andrew Witty
  GE Healthcare expands manufacturing operations in India
  Sanofi-aventis, Merck tie up to form animal health divison
  International Symposium on Alcohol fuels starts in Delhi

BioSpectrum Japan is uniquely positioned as a specialized information platform for Japanese medical technology articles. It brings to you comprehensive coverage and useful Japan medical news in the areas of pharmaceuticals industry in Japan, Japanese medical technology, Japan medical devices and Biotech.
Advertisement
 
Digital Mag
Read on some of the best articles published in 2009

Issue: February, 2010
Current Issue
View / Download
Top Story
India puts bt brinjal on hold
 
 
 
Print Edition
Issue: Feb 2010
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement











 

NEWS
Shionogi to market QuatRx Pharmas' Ospemifene
Japanese pharma company Shionogi and QuatRx Pharmaceuticals, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator
Astellas launches $3.5 bn hostile bid for OSI Pharmaceuticals
Japan's Astellas Pharma has launched a hostile bid to acquire OSI Pharmaceuticals, a Nasdaq listed developer of molecular targeted therapies for oncology, diabetes and obesity
FEATURES
OutBound: Japan industry on the move
The future is in innovative R&D and export markets
A lot of players will emerge in the stem cell industry"
Stem cell related businesses will organically diversify into cell therapy, drug discovery, tailor-made medicine, and research reagents
PEOPLE
GSK Japan gets new President
GlaxoSmithKline has appointed Mr Philippe Fauchet as the President of GSK Japan. Mr Fauchet joins GSK from Sanofi Aventis where he was Senior Vice President, Business Development
Nu Skin Japan appoints Dr Makoto Kuro-O to its SAB
Nu Skin Japan also announced Dr Makoto Kuro-O, associate professor of pathology at the University of Texas Southwestern Medical Center, as a new member of its Anti-Aging Scientific Advisory Board (SAB)
EVENTS
TriNation Health Tech Forum: American Cities to share med tech advances with Japan
The Forum is focused on bringing together the medical devices and e-health technology communities of Western Canada, Washington State and Oregon with delegates from Japan
Medidata participates in clinical data workshop in Japan
Medidata Solutions announced that its top executives will present at the 11th Annual Workshop for Clinical Data Management in Tokyo, Japan
R & D
Japanese researchers trace HMGB1 protein that triggers islet cell rejection
Researchers at RIKEN and Fukuoka University in Japan have pinpointed the mechanism responsible for early rejection of transplanted pancreatic islet cells in the treatment of type 1 diabetes, also known as juvenile diabetes. A new system based on this
A kind of catechin in green tea can prevent infection by flu virus
Joint research conducted by the Central Research Institute of ITO EN and Professor Takashi Suzuki of the School of Pharmaceutical Sciences, University of Shizuoka, showed that epigallocatechin gallate, a kind of catechin contained in green tea
POLICIES
Daiichi to make hypertension combo therapy in Japan
Drug major Daiichi Sankyo has received approval in Japan to manufacture and market Rezaltas combination tablets LD and HD for the treatment of hypertension.
Novartis gets Japanese approval for three medicines
Novartis has received Japanese drug regulator's nod to launch three medicines for Diabetes, high BP and kidney cancer
PRODUCTS
Abbott's XIENCE V gets MHLW approval
Abbott announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. The company plans to launch XIENCE V in Japan soon
Nu Skin launches ageLOC product in Japan
Nu Skin Enterprises introduced the new ageLOC Future Serum to more than 10,000 sales representatives at its launch event in Japan. Japanese distributors were eager to be in the first market to fully launch one of the company's new ageLOC skin care
TRENDS & ANALYSIS
Japanese peripheral vascular stent procedures to expand at 11 % CAGR till 2014
According to Millennium Research Group, Japan's complex regulatory environment and lengthy device approval process has created a significant lag in peripheral vascular stenting device availability in the country compared to other developed nations
Patent protection of depression drugs will drive growth in Europe, Japan
The new Pharmacor report entitled Major Depressive Disorder finds that sales of therapies for major depression in most of Europe and Japan will increase by $500 million from 2008 to 2018
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black